NCT07199452View on ClinicalTrials.gov

A Study of Rifabutin and MK-4646 in Healthy Participants (MK-4646-004)

PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

18

Participants

Timeline

Start Date

October 28, 2025

Primary Completion Date

December 27, 2025

Study Completion Date

December 27, 2025

Conditions

Healthy

Interventions

DRUG

MK-4646

Oral Capsule

DRUG

Rifabutin

Oral Capsule

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY